YYForce Inc. announced its vision to develop an integrated platform that combines human expertise, AI, robotics, and IoT systems to support next-generation smart hotel operations. The platform aims to coordinate staffing, service delivery, robotic tasks, and building performance, enhancing efficiency and guest comfort while reducing energy use. This initiative lays the groundwork for future superintelligent applications in hospitality, focusing on data integration, task coordination, and operational oversight. YYForce emphasizes this as a long-term strategy, with ongoing development and testing before broader deployment.
YYForce's integration of human, AI, robotics, and IoT platforms for smart hotel operations is presented here alongside Pluang's Technology sector data as of Oct 23, 2026 15:31 WIB. Among 150 US technology stocks, 72 rose and 66 fell. Notably, AXTI gained 8.09% with a 74% buy order activity and a typical hold time of 18 days, contrasting with NOK's 6.61% rise and 86% buy activity over 66 days, while INFY declined 4.69% with 100% sell orders and a 27-day hold time.
The global motorsports market is projected to grow from $11.45 billion in 2026 to $16.17 billion by 2031, with a CAGR of 7.15%. Growth is fueled by expanding digital rights, streaming platforms, and increased sponsorship opportunities, especially in ...
YYForce Inc. announced a new integrated platform that connects human expertise, AI, robotics, and IoT systems to enhance hotel operations. This platform aims to coordinate staffing, robotic tasks, and building performance, preparing the hospitality s...
YYForce Inc. announced a new integrated platform designed to connect human expertise, AI, robotics, and smart building technologies in hotels. This platform aims to streamline hotel operations by coordinating staffing, service delivery, robotic tasks...
BDR Pharmaceuticals has filed a lawsuit against the FDA, disputing the agency's refusal to accept an abbreviated new drug application referencing Phathom Pharmaceuticals' VOQUEZNA. BDR claims the FDA wrongly extended Phathom's exclusivity period unde...
Ipsos achieved 2.0% organic revenue growth in Q3 2026, up from 0.8% in H1, driven by strong performances in EMEA, China, and citizen-related activities. The company updated its 2026 organic growth target to 1.2%-1.5%, reflecting improved momentum and...
